Skip to content

Calcium Intake and Fat Excretion

Calcium Intake and Fat Excretion - an Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01542164
Acronym
KIFU/B266
Enrollment
158
Registered
2012-03-02
Start date
2010-06-30
Completion date
2011-08-31
Last updated
2017-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Energy Excretion, Fat Excretion

Keywords

Calcium intake, Fat excretion, Energy excretion, Gut micro flora

Brief summary

The overall purpose of this study is to examine the effect of calcium on fecal fat and energy excretion.

Detailed description

Several reports have found inverse associations between calcium intake and body weight. Few intervention studies have shown that a high calcium diet resulted in a greater body weight loss than a low calcium diet. The mechanism is not clear, but one possible explanation is reduced absorption of fat in the gut, due to formation of insoluble calcium fatty acid soaps or binding of bile acids which impairs the formation of micelles. The aim of this study is to examined for an association between habitual calcium intake and fecal energy and fat excretion, concentrations of substrates involved in energy metabolism, blood pressure and body weight

Interventions

None listed

Sponsors

The Ministry of Science, Technology and Innovation, Denmark
CollaboratorOTHER_GOV
Arla Foods
CollaboratorINDUSTRY
The Danish Dairy Research Foundation, Denmark
CollaboratorOTHER
University of Copenhagen
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* age between 18 - 50 years * healthy * weight stable within 4 months prior to the inclusion

Exclusion criteria

* pregnant or lactating * uses cholesterol lowering drugs * on diet * suffering from, now or previously, any gastrointestinal diseases * elite athletes * participation in other concomitant trial

Design outcomes

Primary

MeasureTime frameDescription
Total fat and energy excretion5 daysTotal fat and energy excretion in faeces during the test period of 5 consecutive days

Secondary

MeasureTime frameDescription
p-PTH1 dayParathyroid hormone (PTH)
Selected genetic variations1 dayDNA from blood sample
Blood lipids and cholesterol1 dayTotal p-cholesterol, p-LDL, p-HDL, p-TG and p-FFA
p-vitamin D1 day
Gut micro flora1 dayIdentification of gut micro flora
NMR-spectroscopy based metabonomics profiling of urin1 dayNMR-spectroscopy based metabonomics profiling of each test subject
blood pressure1 dayResting blood pressure
calcium excretion2 daysTotal calcium excretion in faeces and urin during the test period of 2 consecutive days

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026